Verastem, Inc. Equity-NMS: VSTM

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$7.77
Open :$7.7
Today's high :$7.77
Today's low :$7.16
52W low :$2.1
52W high :$9.1
EPS(TTM): :-3.43
Shares O/S :54.95 M
Market cap :413.22 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Verastem, Inc. $7.52 -0.02% - 413.22M

Frequently Asked Questions

What is the share price of Verastem, Inc. today?

Verastem, Inc. (VSTM) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Verastem, Inc.

Verastem, Inc. is a late-stage development biopharmaceutical company, which focuses on the development and commercialization of new medicines to improve the lives of patients diagnosed with ras sarcoma (RAS)/ mitogen-activated pathway kinase (MAPK) pathway-driven cancers. Its product candidates include avutometinib and defactinib. Avutometinib is an oral RAF/MEK clamp that inhibits MEK1/2 kinase activities and induces inactive complexes of MEK with A-Raf proto-oncogene, potentially serine/threonine kinase (ARAF), B-Raf proto-oncogene serine/threonine kinase (BRAF) and C-raf proto-oncogene serine/threonine kinase, creating antitumor response through maximal RAS/MAPK pathway inhibition. Defactinib is an oral, selective inhibitor of FAK and proline-rich tyrosine kinase (PYK2), the two members of the focal adhesion kinase family of non-receptor protein tyrosine kinases. FAK and PYK2 integrate signals from integrin and growth factor receptors to regulate cell proliferation.